Table 2:
Characteristics and serum copeptin concentrations during GH testing for the Outlier group
| Sex | Age (years) |
Stimulating Agent(s) |
Copeptin (pmol/L) | %decrease from 0 to 120 minutes |
Anxiety | ||||
|---|---|---|---|---|---|---|---|---|---|
| −20 minutes |
0 minutes |
60 minutes |
90 minutes |
120 minutes |
|||||
| Male | 11.5 | Arg-Clon | - | 62 | 42 | 39 | 33 | 47% | Not Present |
| Male | 14.5 | Arg-Insulin | - | 471 | 130 | 140 | 71 | 85% | Present |
| Male | 15.0 | Arg-Insulin | - | 362 | 65 | 87 | 48 | 86% | Present |
| Female | 15.7 | Insulin | - | 202 | 51 | 40 | 29 | 86% | Present |
| Male | 7.2 | Arg-L-Dopa /Carbidopa | - | 1361 | 282 | 355 | 194 | 86% | Not Present |
| Male | 13.5 | Arg-L-Dopa /Carbidopa | 158 | 106 | 126 | 65 | 67 | 58% | Present |
| Female | 11.9 | Arg-L-Dopa /Carbidopa | 71 | 61 | 33 | 26 | 28 | 61% | Not Present |
| Female | 9.1 | Arg-L-Dopa /Carbidopa | 42 | 40 | 36 | 39 | 38 | 9% | Present |
Abbreviations: Arg, arginine; Clon, clonidine